Vasconcelos Daniela Moulin Maciel de, Chaves Gabriela Costa, Azeredo Thiago Botelho, Silva Rondineli Mendes da
Departamento de Política de Medicamentos e Assistência Farmacêutica, Escola Nacional de Saúde Pública, Fiocruz. R. Leopoldo Bulhões 1480, Manguinhos. 21041-210 Rio de Janeiro RJ Brasil.
Observatório de Vigilância e Uso de Medicamentos, Faculdade de Farmácia, Universidade Federal do Rio de Janeiro. Rio de Janeiro RJ Brasil.
Cien Saude Colet. 2017 Aug;22(8):2609-2614. doi: 10.1590/1413-81232017228.02432017.
Pharmaceutical services and the formulation of a medicines policy are SUS areas ensured by the organic health care law 8,080/90. Thus, after a widely participative process, involving stakeholders, the National Medicines Policy (NMP) was approved in 1998 by Ordinance 3,916.The NMP presents directives and priorities, aligned with organic health care law, which should guide the federal, states and municipals entities actions to achieve the policy goals. Considering almost 20 years of the NMP, this paper took stock discussed some of the directives in light of the SUS principles. It was not the objective to provide an exhaustive review of all the activities performed during this period. The authors tried to get close to those that have brought advances and dilemmas, with potential risk of regression. Efforts to implement an ambitious agenda applied to pharmaceutical services were identified. This agenda tried to deal with different challenges like the dynamics of the pharmaceutical market and the operation of pharmaceutical services to guarantee the supply of medicines aligned with principles and directives of SUS.
制药服务和药品政策的制定是《第8080/90号有机医疗保健法》所保障的统一医疗体系（SUS）领域。因此，在经过广泛参与的过程，涉及利益相关者后，《国家药品政策》（NMP）于1998年由第3916号法令批准。《国家药品政策》提出了与有机医疗保健法相一致的指令和优先事项，应指导联邦、州和市实体的行动以实现政策目标。考虑到《国家药品政策》已实施近20年，本文进行了总结，并根据统一医疗体系原则讨论了一些指令。本文并非旨在详尽回顾这一时期开展的所有活动。作者试图接近那些带来进步和困境、存在倒退潜在风险的活动。确定了为实施适用于制药服务的雄心勃勃议程所做的努力。该议程试图应对不同挑战，如药品市场动态和制药服务运营，以确保药品供应符合统一医疗体系的原则和指令。
